Latest Headlines

Latest Headlines

Crucell reports early-stage success with TB vaccine

Shares of Crucell jumped after the developer announced that an early-stage trial of an experimental tuberculosis vaccine demonstrated a promising immune response in volunteers. The Dutch biotech is

Sanofi licenses technology for new TB vaccine

Sanofi Pasteur has struck a licensing deal with the Statens Serum Institut of Denmark covering the use of its technology for a new tuberculosis vaccine. The pact includes SSI's Intercell IC31

Biotech nonprofit to make meds with donated IP

The Connecticut biotech group CURE has set up a nonprofit subsidiary and staffed it with a couple of experienced R&D specialists out to turn the drug development world's cast-offs into low-cost